TABLE 2.
Location of isolation by continent | Yr of isolation | No. investigated (+ no. of reference strains investigated) (dimorphic form)a | Method used (source) | MIC/MIC range (μg/ml) forb: |
Reference or source | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
AMB | ITC | VRC | POS | ISA | FLU | CAS/MFG/AFGc | RAV | |||||
North America | ||||||||||||
St. Louis, MO | 1990 | 8 + 4 (Y) | Broth microdilution using SDBd | 0.30 to 1.04 | 2.95 to >1,000 | 12 | ||||||
Indiana | 1997 | 1 (Y) | Broth macrodilution (NCCLS) | 0.004 | 0.62 (parent), 1.25 (8th wk), 2.5 (12th wk), 20 (16th wk) | 14 | ||||||
Virginia | 1998 | 5 (M) | Broth microdilution (NCCLS) | 0.25 to 0.5 | 0.06 | 0.06 | 15 | |||||
Virginia | 1998 | 5 (M) | Broth microdilution (NCCLS) | 0.04 | CAS, 1.3; AFG, 3.6 | 16 | ||||||
Indiana | 2000 | 20 (Y) | Modified broth microdilution (NCCLS M-27A) | 0.5 to 1 | 8 to 32 | 11 | ||||||
Texas | 2000 | 100 (M) | Modified broth microdilution (NCCLS M-27A) | <0.03 to 2 | <0.03 to 0.5 | <0.03 to 2 | 17 | |||||
Indiana | 2001 | 65 (M) | Modified broth microdilution (NCCLS M-27A) | 0.019 to 0.077 | 0.31 to 10 | 8 | ||||||
Virginia | 2003 | 4–5 (M) | Broth macrodilution (NCCLS M38-A) | 0.06 to 0.5 | <0.01 to 0.03 | <0.03 to 0.06 | 1 to 16 | CAS, 0.5 to 4; AFG, 2 to 4; MFG, >0.03 to 0.06 | 18 | |||
Mexico | 2005 | 28 (M) | Broth macrodilution (NCCLS M38-A) | 0.06 to 1 | 0.06 to 2 | 0.03 to 2 | 2 to 32 | 0.125 to 2 | 19 | |||
Indiana | 2006 | 17 (median MIC) (Y) | Broth microdilution (NCCLS M-27A) | 0.015 | 0.007 | 1 | 0.007 | 20 | ||||
Mexico | 2009 | 28 (M) | Broth macrodilution (CLSI M38-A) | 0.06 to 0.25 | 0.25 to 2 | 0.06 to 2 | 0.03 to 2 | 0.125 to 2 | 4 to 32 | 9 | ||
South America | ||||||||||||
Brazil | 2012 | 68 (M) | Modified broth microdilution (NCCLS M38-A) | 0.007 to 0.5 | 0.001 to 0.031 | 0.0078 to 0.5 | 3.9 to 125 | 0.016 to 32 | 21 | |||
8 (Y) | Modified broth microdilution (CLSI M27-A2) | 0.06 to 0.5 | 0.0039 to 0.03 | 0.002 to 0.03 | 3.9 to 7.8 | 1 to 4 | ||||||
Asia | ||||||||||||
Japan | 2010 | 3 (M) | Modified broth microdilution (CLSI M38-A) | 0.013 to 0.05 | <0.0004 | 0.006 to 0.025 | 0.003 to 0.006 | 0.55 to 1.2 | 22 | |||
India | 2014 | 21 + 2 (M) | Modified broth microdilution (CLSI M38-A2) | 0.03 to 0.25 | <0.03 to 0.125 | <0.03 to 0.25 | 0.015 to 0.125 | 0.015 to 0.25 | 2 to 32 | 0.015 to 0.5 | Present study | |
21 + 2 (Y) | Modified broth microdilution (CLSI M27-A3) | 0.03 to 0.5 | 0.03 to 0.25 | 0.03 to 0.5 | 0.03 to 0.5 | 0.015 to 0.125 | 2 to 8 | 0.03 to 1 |
M, mycelial form; Y, yeast form.
AMB, amphotericin B; ITC, itraconazole; VRC, voriconazole; POS, posaconazole; ISA, isavuconazole; FLU, fluconazole; CAS, caspofungin; RAV, ravuconazole; MFG, micafungin; AFG, anidulafungin.
For caspofungin, MEC were defined for testing the mycelial form.
SDB, Sabouraud's dextrose broth.